S&P 500   3,849.62
DOW   30,937.04
QQQ   328.59
S&P 500   3,849.62
DOW   30,937.04
QQQ   328.59
S&P 500   3,849.62
DOW   30,937.04
QQQ   328.59
S&P 500   3,849.62
DOW   30,937.04
QQQ   328.59
Log in
CNSX:PREV

(PREV) Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range
$0.03
MA: $0.04
$0.06
52-Week Range N/A
Volume694,224 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
PreveCeutical Medical Inc., a health sciences company, develops options for preventive and curative therapies utilizing organic and nature identical products in the United States and Canada. It has research and development programs, including dual gene therapy for curative and prevention therapies for type 2 diabetes and obesity; a soluble gel drug delivery program, which provide relief from pain, inflammation, seizures, and neurological disorders; Nature Identical peptide therapeutic applications; non-addictive analgesic peptides as a replacement to the addictive analgesics, such as morphine, fentanyl, and oxycodone; and a therapeutic product for treating athletes who suffer from concussions. It also provides medicinal cannabis-based products. PreveCeutical Medical Inc. is headquartered in Vancouver, Canada.

MarketRank

Overall MarketRank

0.66 out of 5 stars

Analyst Opinion: 0.0Community Rank: 3.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone604-416-7777
EmployeesN/A
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Next Earnings DateN/A
OptionableNot Optionable
30 days | 90 days | 365 days | Advanced Chart

Receive PREV News and Ratings via Email

Sign-up to receive the latest news and ratings for PREV and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











(PREV) (CNSX:PREV) Frequently Asked Questions

What stocks does MarketBeat like better than (PREV)?

Wall Street analysts have given (PREV) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but (PREV) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are some of (PREV)'s key competitors?

What other stocks do shareholders of (PREV) own?

Who are (PREV)'s key executives?

(PREV)'s management team includes the following people:
  • Mr. Stephen Van Deventer, Chairman & CEO (Age 51, Pay $172.94k)
  • Dr. Makarand Jawadekar Ph.D., Chief Science Officer, Pres & Director (Age 69, Pay $212.45k)
  • Ms. Shabira Rajan CPA, CGA, CFO & Controller (Age 64, Pay $152.63k)
  • Dr. Harendra Parekh Ph.D., BSc., Hons I, MRPharmS, Chief Research Officer

What is (PREV)'s stock symbol?

(PREV) trades on the CNSX under the ticker symbol "PREV."

How do I buy shares of (PREV)?

Shares of PREV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is (PREV)'s official website?

The official website for (PREV) is www.preveceutical.com.

How can I contact (PREV)?

The company can be reached via phone at 604-416-7777.

This page was last updated on 1/27/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.